Estrogenic effect of the MEK1 inhibitor PD98059 on endogenous estrogen receptor alpha and beta

Journal of Steroid Biochemistry and Molecular Biology

Volumn 124, Issue 1-2, 2011, Pages 25-30

  Cotrim, Cândida Z ^a   Amado, Francisco L ^a   Helguero, Luisa A ^a,b  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Estrogen receptors; Flavone; Gene expression; Mammary epithelial cells; PD98059

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; SMALL INTERFERING RNA;

ARTICLE; BREAST EPITHELIUM; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; ESTROGEN ACTIVITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPORTER GENE;

BLOTTING, WESTERN; CELL GROWTH PROCESSES; CELL LINE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; FLAVONOIDS; HUMANS; MAMMARY GLANDS, HUMAN; MITOGEN-ACTIVATED PROTEIN KINASE 1; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; TRANSFECTION;

EID: 79952040108     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.12.020     Document Type: Article

References (22)

1. E.A. Musgrove, and R.L. Sutherland Biological determinants of endocrine resistance in breast cancer Nat. Rev. Cancer 9 2009 631 643
2. K.F. Koehler, L.A. Helguero, L. Haldosén, M. Warner, and J. Gustafsson Reflections on the discovery and significance of estrogen receptor beta Endocr. Rev. 26 2005 465 478 (Pubitemid 40691301)
3. V. Speirs, and R.A. Walker New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast J. Pathol. 211 2007 499 506 (Pubitemid 46502425)
4. L.A. Helguero, M.H. Faulds, J. Gustafsson, and L. Haldosén Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11 Oncogene 24 2005 6605 6616 (Pubitemid 41486791)
5. G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, P. van der Saag, B. van der Burg, and J. Gustafsson Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 139 1998 4252 4263 (Pubitemid 28513713)
6. M.J. Meyers, J. Sun, K.E. Carlson, G.A. Marriner, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues J. Med. Chem. 44 2001 4230 4251 (Pubitemid 33095330)
7. S.R. Stauffer, C.J. Coletta, R. Tedesco, G. Nishiguchi, K. Carlson, J. Sun, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists J. Med. Chem. 43 2000 4934 4947 (Pubitemid 32040974)
8. R. Cermak Effect of dietary flavonoids on pathways involved in drug metabolism Expert Opin. Drug Metab. Toxicol. 4 2008 17 35 (Pubitemid 351234098)
9. X.O. Shu, Y. Zheng, H. Cai, K. Gu, Z. Chen, W. Zheng, and L. Wei Soy food intake and breast cancer survival JAMA 302 2009 2437 2443
10. D.T. Dudley, L. Pang, S.J. Decker, A.J. Bridges, and A.R. Saltiel A synthetic inhibitor of the mitogen-activated protein kinase cascade Proc. Natl. Acad. Sci. U.S.A. 92 1995 7686 7689
11. Z. Dang, and C.W.G.M. Lowik Differential effects of PD98059 and U0126 on osteogenesis and adipogenesis J. Cell. Biochem. 92 2004 525 533
12. M.H. Faulds, H. Olsen, L.A. Helguero, J. Gustafsson, and L. Haldosén Estrogen receptor functional activity changes during differentiation of mammary epithelial cells Mol. Endocrinol. 18 2004 412 421 (Pubitemid 38185881)
13. X. Long, E.A. Gize, K. Nephew, and R.M. Bigsby Evidence for estrogenic contamination of the MAPK inhibitor PD98059 Endocrinology 142 2001 5390 5393 (Pubitemid 33131973)
14. L. Ciarloni, S. Mallepell, and C. Brisken Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development Proc. Natl. Acad. Sci. U.S.A. 104 2007 5455 5460 (Pubitemid 47175701)
15. C.K. Osborne, J. Shou, S. Massarweh, and R. Schiff Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer Clin. Cancer Res. 11 2005 865s 870s (Pubitemid 40111098)
16. J. Legler, C.E. van den Brink, A. Brouwer, A.J. Murk, P.T. van der Saag, A.D. Vethaak, and B. van der Burg Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line Toxicol. Sci. 48 1999 55 66 (Pubitemid 29244421)
17. V.S. Likhite, F. Stossi, K. Kim, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity Mol. Endocrinol. 12 2006 3120 3132 (Pubitemid 44833560)
18. M.C. Canivenc-Lavier, M.F. Vernevaut, M. Totis, M.H. Siess, J. Magdalou, and M. Suschetet Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver Toxicology 114 1996 19 27 (Pubitemid 26379364)
19. C. Brouard, M.H. Siess, M.F. Vernevaut, and M. Suschetet Comparison of the effects of feeding quercetin or flavone on hepatic and intestinal drug-metabolizing enzymes of the rat Food Chem. Toxicol. 26 1998 99 103
20. J.J. Reiners, J.-Y. Lee, R.E. Clift, D.T. Dudley, and S.P. Myrand PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase Mol. Pharmacol. 53 1998 438 445 (Pubitemid 28162865)
21. E. Swedenborg, J. Rüegg, S. Mäkelä, and Pongratz Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders J. Mol. Endocrinol. 43 2009 1 10
22. J. Rüegg, E. Swedenborg, D. Wahlström, A. Escande, P. Balaguer, K. Pettersson, and I. Pongratz The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor beta-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin Mol. Endocrinol. 22 2008 304 316 (Pubitemid 351185933)